Lester Reich

647 total citations
16 papers, 296 citations indexed

About

Lester Reich is a scholar working on Toxicology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lester Reich has authored 16 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Toxicology, 4 papers in Pharmacology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lester Reich's work include Pharmacovigilance and Adverse Drug Reactions (12 papers), Drug-Induced Adverse Reactions (4 papers) and Academic integrity and plagiarism (3 papers). Lester Reich is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (12 papers), Drug-Induced Adverse Reactions (4 papers) and Academic integrity and plagiarism (3 papers). Lester Reich collaborates with scholars based in United States, United Kingdom and Germany. Lester Reich's co-authors include Manfred Hauben, Charles M. Gerrits, Sebastian Horn, Stephanie T. Chung, Louisa Walsh, Vaishali Patadia, Muhammad Younus, Muhammad Younus, David Madigan and David Goldsmith and has published in prestigious journals such as British Journal of Clinical Pharmacology, Infection Control and Hospital Epidemiology and Journal of Psychopharmacology.

In The Last Decade

Lester Reich

16 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lester Reich United States 11 193 88 59 50 42 16 296
Suzie Seabroke United Kingdom 8 216 1.1× 82 0.9× 67 1.1× 43 0.9× 24 0.6× 12 418
Johan Hopstadius Sweden 7 284 1.5× 116 1.3× 86 1.5× 98 2.0× 23 0.5× 8 506
Joseph M. Tonning United States 9 196 1.0× 98 1.1× 75 1.3× 48 1.0× 11 0.3× 13 503
Nancy Yuen United States 7 287 1.5× 102 1.2× 104 1.8× 83 1.7× 20 0.5× 9 534
Yasunori Aoki Japan 12 82 0.4× 47 0.5× 50 0.8× 50 1.0× 16 0.4× 36 400
Katrin Manlik Germany 4 189 1.0× 74 0.8× 51 0.9× 41 0.8× 12 0.3× 6 238
Vaishali Patadia United States 9 347 1.8× 116 1.3× 92 1.6× 91 1.8× 25 0.6× 13 525
Andreas Brueckner United States 7 97 0.5× 31 0.4× 49 0.8× 28 0.6× 17 0.4× 12 356
Gianmario Candore Netherlands 9 326 1.7× 100 1.1× 106 1.8× 56 1.1× 30 0.7× 18 515
Eileen Wu United States 11 95 0.5× 23 0.3× 32 0.5× 51 1.0× 73 1.7× 23 378

Countries citing papers authored by Lester Reich

Since Specialization
Citations

This map shows the geographic impact of Lester Reich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lester Reich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lester Reich more than expected).

Fields of papers citing papers by Lester Reich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lester Reich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lester Reich. The network helps show where Lester Reich may publish in the future.

Co-authorship network of co-authors of Lester Reich

This figure shows the co-authorship network connecting the top 25 collaborators of Lester Reich. A scholar is included among the top collaborators of Lester Reich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lester Reich. Lester Reich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Reich, Lester, et al.. (2011). Putting the Cardiovascular Safety of Aromatase Inhibitors in Patients with Early Breast Cancer into Perspective. Drug Safety. 34(12). 1125–1149. 16 indexed citations
2.
Younus, Muhammad, et al.. (2009). Antidepressants that inhibit neuronal norepinephrine reuptake are not associated with increased spontaneous reporting of cardiomyopathy. Journal of Psychopharmacology. 24(4). 503–511. 10 indexed citations
3.
Hauben, Manfred, Lester Reich, Charles M. Gerrits, & David Madigan. (2007). Detection of Spironolactone-Associated Hyperkalaemia Following the Randomized Aldactone Evaluation Study (RALES). Drug Safety. 30(12). 1143–1149. 16 indexed citations
4.
Hauben, Manfred, Lester Reich, Charles M. Gerrits, & Muhammad Younus. (2007). Illusions of objectivity and a recommendation for reporting data mining results. European Journal of Clinical Pharmacology. 63(5). 517–521. 18 indexed citations
5.
Hauben, Manfred, Sebastian Horn, & Lester Reich. (2007). Potential Use of Data-Mining Algorithms for the Detection of ???Surprise??? Adverse Drug Reactions. Drug Safety. 30(2). 143–155. 30 indexed citations
6.
Hauben, Manfred, Sebastian Horn, Lester Reich, & Muhammad Younus. (2007). Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools. International Journal of Infectious Diseases. 11(5). 417–422. 14 indexed citations
7.
Hauben, Manfred, et al.. (2007). Postmarketing hepatic adverse event experience with PEGylated/non-PEGylated drugs: a disproportionality analysis. European Journal of Gastroenterology & Hepatology. 19(11). 934–941. 4 indexed citations
8.
Hauben, Manfred, Lester Reich, & Charles M. Gerrits. (2006). Reports of hyperkalemia after publication of RALES—a pharmacovigilance study. Pharmacoepidemiology and Drug Safety. 15(11). 775–783. 15 indexed citations
9.
Hauben, Manfred, et al.. (2006). Drug-Induced Psoriasis: Results from Pharmacovigilance Tools under Investigation. Drug Safety. 29(10). 911–1010. 1 indexed citations
10.
Hauben, Manfred & Lester Reich. (2005). Potential Utility of Data‐Mining Algorithms for Early Detection of Potentially Fatal/Disabling Adverse Drug Reactions: A Retrospective Evaluation. The Journal of Clinical Pharmacology. 45(4). 378–384. 29 indexed citations
11.
Hauben, Manfred & Lester Reich. (2005). Endotoxin-Like Reactions With Intravenous Gentamicin Results From Pharmacovigilance Tools Under Investigation. Infection Control and Hospital Epidemiology. 26(4). 391–394. 5 indexed citations
12.
Hauben, Manfred, Vaishali Patadia, Charles M. Gerrits, Louisa Walsh, & Lester Reich. (2005). Data Mining in Pharmacovigilance. Drug Safety. 28(10). 835–842. 42 indexed citations
13.
Hauben, Manfred & Lester Reich. (2005). Response to letter by Levineet al.. British Journal of Clinical Pharmacology. 61(1). 115–117. 9 indexed citations
14.
Hauben, Manfred, Lester Reich, & Stephanie T. Chung. (2004). Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms. European Journal of Clinical Pharmacology. 60(10). 747–750. 36 indexed citations
15.
Hauben, Manfred & Lester Reich. (2004). Safety Related Drug-Labelling Changes. Drug Safety. 27(10). 735–744. 42 indexed citations
16.
Hauben, Manfred, et al.. (1995). Multiple Cholesterol Emboli Syndrome—Six Cases Identified Through the Spontaneous Reporting System. Angiology. 46(9). 779–784. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026